tm logo

Monitor this mark

View On USPTO

JEMVASO
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 28 May 2024

Last Applicant/ Owned by

Protara Therapeutics, Inc.

345 Park Avenue South, 3rd Floor

New York

NY

10010

Serial Number

97140192 filed on 23rd Nov 2021

Registration Number

N/A

Correspondent Address

Jared M. Barrett

Jared M. Barrett Seed IP Law Group LLP

Seattle, WA 98104

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

JEMVASO

Pharmaceutical preparations, namely, lyophilized inactivated Group A Steptococcus preparation for the treatment and prevention of lymphatic malformations

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, lyophilized inactivated Group A Steptococcus preparation for the treatment and prevention of lymphatic malformations

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97140192

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 120261.20004

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
25th Nov 2024SOU TEAS EXTENSION RECEIVED
29th May 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28th May 2024SOU TEAS EXTENSION RECEIVED
28th May 2024SOU EXTENSION 3 FILED
28th May 2024SOU EXTENSION 3 GRANTED
29th Nov 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29th Nov 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
29th Nov 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29th Nov 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
23rd Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED